Ever since the company’s first operational year in 1991, Farmatek has been importing hemophilia and intensive care products of CSL Behring, one of the market leaders thanks to its reliable biotechnology and plasma products.

Benzamycin® topical gel, the leading anti-acne product in its class was first launched in 1997, and Benzalin® Topical Gel, which is also indicated for acne treatment, was introduced to physicians and pharmacists in 2011.

Driven by its topical steroid products that are indicated in different forms of dermatitis Farmatek continues to reinforce its position in Dermatology. Our products in this field include Belogent®, Dermabel® and Betasalic®.

In cardiology, Nitrolingual® Pump Spray indicated in angina pectoris treatment and Kalinor® Effervescent Tablet used for hypokalemia treatment were introduced to physicians and pharmacists.

Farmatek expanded its business to include the Urology market with Gepan® Instill, which is used in chronic cystitis treatment and Kalinor® Effervescent Tablet used for kidney stone prophylaxis.

Within sight of its goals for growth, Farmatek signed co-marketing and new partnership deals in 2015, enabling the company to launch sales and marketing activities of the Central Nervous System products. The contract with Egis expanded our product range of antipsychotics and antidepressants.

Farmatek continues to invest in dermatology LoB and introduced Dermifin® Cream / Spray, Opilox Nail Polish and topical immunmodulator Tacrolin Ointment in topical antifungals market.

In 2016, Farmatek expanded its business to nephrology with Paridev® Ampoule and Sevaren® Tablet, which are used in treating dialysis patients.

In 2017, Farmatek launched Nefovir Tablet, Viratit Tablet and Citovir® Tablet in antiviral LoB.

We also established the Rare Diseases division in 2017 and started to import Infasurf Vial, which is used for lung development in premature babies.

For more information about our products, you can choose from the product groups on the left menu or use the search engine.